...can be difficult to achieve in many bacterial stra... and modification (R-M) systems that cleave unmodi...#153; Restriction Inhibitor provides a powerful me... bacterial strains with type I R-M systems. Devel...
Agencourt AMPure 96 Starter Kit from Agencourt Bioscience
...d for the fast and simple integration of loxP-site...the generation of transgenic mouse models). The in...to allow neomycin / kanamycin selection in prokary...ic promoter (gb2) for expression of kanamycin resi...
Pyrex brand baffled trypsinizing flask, with beaded neck from Sigma-Aldrich
Biology Products:(Date:11/24/2009)...Call/--Sigma-AldrichCorporation(Nasdaq: SIAL )will...mber1stat1:45PMGMTinLondon,7:45AMUS/CST.Interested...etavailableat http://inve s tor.sig m a a l...thisfile. ,, AboutSigma-Aldrich: Sigma-Aldri...schemicalandbiochemicalproductsandkitsareusedinsci...
(Date:11/24/2009)...e-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abioph...lizingnovelpainmanagementtherapies,announcedtodayt...r,isscheduledtopresentatthe21stAnnualPiperJaffrayH...ewYorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTon...availabletorespondtoquestionsduringthepresentation...
(Date:11/24/2009)...tforpatientswithadvanced-stage,orrecurrentendometr...stCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)...sedonendocrinetherapyandoncology,todayannouncedpos...totoxicpeptideconjugate,AEZS-108(formerlyAN-152),i...Inapersonalizedhealthcareapproach,thestudyselected...
(Date:11/24/2009)...wire-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )...iveChairman,willpresentatthe21stAnnualPiperJaffray...r1,2009at10:00a.m.ET. ,, Toaccesstheliveandsubs...nvestorRelationssectionofGenomicHealth,swebsiteat ...thewebsiteatleast15minutespriortothebeginningofthe...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2